The outlook of companies tied to Sildenafil's legacy presents a challenging investment picture . While the initial surge generated substantial profits , generic alternatives have significantly impacted https://thegreatbookmark.com/story21644699/the-copyright-and-big-pharma-a-uncertain-investment